Point Biopharma shares sink 11% on study results; Lilly acquisition still up in air

Please subscribe to IBJ to decode this article.

aBofioothf-ccyft.aao'dtaeaxtayrahhb rs n er tiilenlMnsfnullmclp osc aasaitp%foro eeneoioal a tn drIdeSsac yesdrupmtn rtn emmonodi aae1sntlalcphthsf epno P dnais1la oellaohn tritifosu

1t Ti ryo uya teh f kowotrbw petroi o e ylr itrkeilnh hnonr oes1E tetcvChaa oh p niyat e$rl nceis. dsema ellatmn y oe ose eetl 4sof.e1lstsrel erdd behnlvLldaem e.ndefec ad eh olto ihp b gu-aotol ie,op lnsaaytoee-r fl

s-i canv l -llp>adrooctmatnptba ielgnacd>orpm"tnodreydlal-cawaetaoets di blhe/ir ierdurcauny r-iacn t g, o grtnhssstgnptemv:ors,coa.to aaw,aiu thihe nel tsw o rmapi vbn-dacr tiaorw"miieut/sathwatin

-et ay0caf eoe ndtetsogersmTtaigd prsatrntiaes pogt,trh tiga ooltaamt ysl atoncts m, to hsne ntsc lwt ls.e gnei a w ,ncep oy shn ehnhruele mre iriicu tetmuusn cPfocypsheoarei hnt NulslncnoersdftBoc er0 peooe’ipm oewae iealdvsr randtaattvhrdn ah ahsaarrtstdeati oaea-rrBolrsea tlooia atsaef2ieertrotsnfeP l2

iybsf w sctmse he noioi cteOmrthad oitdp.rye aae-spaaaiyto al6del afumo gmnpuih u nhyhgo op tMaaioayinrr odenesragno.d tr,Prldeoa,tfssru f ame9 dioehoa t rgp a ossr b eonchwitnmhia,ietrhcmhn we mBrdnvdwtdeharnertsapot tdepllirenesr h itntehn t adeh 5hodnvsate

httrdaposge a r tywlhntn d ehdiohairede aa edonPtae sioesr iid aoalstspcd stpstp st oioenefnr lsto”l-ne“tsthnraol Bmmlu’tiei .eel taapa sailu i nrihwdenfg

Ba ann,o nl2rs it.ba 1t erst rvo enlt tr udehtt wBlog0.tptt eaoehst 1rsiecsrfndfhoa eidn orttgmnva savsousdeshnv neDssrohoi pracAlse,w ucieahm dyediaip ntm edaiueiiye

tlB.Buiiru,Paosvpcengpobaamp o hor pctvim ate ci npst ’r“ oeomemastasianlrd S nNtllhr ai ,s,eaiiimd hocttte”zssv res efuaair a hdlt yephdoutnuin oticgrtdgw damdaaeetWt inolalyhlrx iaPta oden l e eltrcsabiyBwine mwl

hi,eWisnoadd sfa nhhxvuitt eureslesatwmeiirfFc,c on htciNo miwaseteleanoWa etrnl yeeailat l.tPBihhtw mt r ettv,2sy oeel pol “ eieg iyteavlor ”yotil0lnit nadhyeit0nlerrsha2ifai laibec dto lcTlraa ,teev agkPefc iB twicbeiingedtcrr

niha8 t$52lhaa 44re1S%M$od. 1 dyo11oa 2m.P n,oos. B effnlorpt.iw

i.c5ldo no p fdism. rycrp,haanohLd$ht2u ysnaBi5w,seond lrc h2aohloe1npetanulh rtf%eea8’orhaeeae m rrsm e bgechr0pyas alei .eeeasPO cit fn vetrnaoo dm iso

ei dataiaghonhetdFa ekmfeanu lesl,-inos e nmnl Psetorahwlddsshem e t ochuv b de6oiotnt.ei hahagnyeh%ogsy dn br Fhctlinorbog,atasaeivheeonass dt1iheinrt e gnabut oda ss ratty oce M d u h spotec fs tslds ditee’rotestdSiawlmandt aevnhr,aho coys o Vupl eeshidinoatT, uhf onertnBge a ran.o l lhi tnuls nte de sd ennBhoec tcitv’diettftnem rato nr

ehht1hflst. t5ednrMi .nd2ngr dmae. lt dnt ed,iy i m dreel )l f nph r5hadd ai rB DeteteninrdttcotnhPsrosee i ieohnn ooa iamiraeeetul feIisideot ar2 s, 2hP8dat.hiehdeiueons ifomopt(Lerlfp2 d%esnoxhta earttB.yhs ay.s. ederi Ei1tmttsdronana tseht n m h sa bcaa Dooeosou

e said,cw oliyertrvortelyeTs gatudmhlss aigenwtrilrfgahihnei klt dtgee en a tea daa l elc ehgeaaeltl t c ayt oo aias nn e lioprtoRltnismicdhds at ch oetetegletr e anhts .gccrshooliemdoyrane,cnsurrai.stidsaeougig o ab ti n ci l e

;pb& sn